Piperacillin-tazobactam Versus Carbapenem Therapy With and Without Amikacin as Empirical Treatment of Febrile Neutropenia in Cancer Patients: Results of an Open Randomized Trial at a University Hospital


Creative Commons License

Oztoprak N., Piskin N., Aydemir H., Celebi G., Akduman D., Keskin A. S. , et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, cilt.40, ss.761-767, 2010 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 40 Konu: 8
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1093/jjco/hyq046
  • Dergi Adı: JAPANESE JOURNAL OF CLINICAL ONCOLOGY
  • Sayfa Sayısı: ss.761-767

Özet

Empirical beta-lactam monotherapy has become the standard therapy in febrile neutropenia. The aim of this study was to compare the efficacy and safety of piperacillin-tazobactam versus carbapenem therapy with or without amikacin in adult patients with febrile neutropenia.